| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | P0EP9VFC4R |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Tumor necrosis factor receptor superfamily member 5 antagonist | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Hodgkin Disease | 1 | D006689 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 1 | D008228 | ClinicalTrials |
| Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1743038 |
| FDA SRS | P0EP9VFC4R |
CONTENTS